DRAM vs KMEM: Which Is the Better Pick in 2026?

Overview

DRAM and KMEM are both thematic equity ETFs focused on memory semiconductor companies, but they differ substantially in scale and track record. DRAM is a $23.7B fund from Roundhill Investments that launched in April 2026, while KMEM is a $26.8M fund from Kurv that began trading in June 2026. Both charge 0.65% expense ratios and target capital appreciation in the memory chip sector rather than income generation.

How they differ

The biggest difference is scale: DRAM has accumulated $23.7 billion in assets versus KMEM's $26.8 million, a roughly 900-to-1 ratio. This gap reflects DRAM's earlier launch date and likely broader distribution, which typically translates to tighter bid-ask spreads and more reliable liquidity for larger positions.

Second, DRAM explicitly permits use of swaps and forward contracts to gain exposure, adding a derivative layer to its strategy, while KMEM describes a direct basket approach to memory semiconductor stocks. That structural choice could affect how closely each fund tracks the underlying memory sector during market dislocations.

Both funds are very new—DRAM is barely into its second quarter of operation and KMEM launched just weeks later—so neither has a meaningful operating history. Neither generates distributions, making them purely capital-appreciation vehicles with no yield to evaluate.

Who each is best for

DRAM: Fits investors seeking thematic exposure to memory semiconductors through a larger, more established fund with easier trading mechanics and lower operational risk from scale.

KMEM: Fits investors who want to test thematic memory exposure through a smaller fund with a direct stock-basket approach, accepting lower liquidity in exchange for potentially simpler underlying mechanics.

Key risks to know

• Thematic concentration risk. Both funds concentrate on a single subsector (memory chips) rather than broad-market or diversified tech exposure. If memory demand softens or competitive dynamics shift—say, toward alternative architectures—both could face sustained pressure in unison.

• Extreme early-stage risk. DRAM and KMEM have operated for fewer than six months. There is no track record to assess performance consistency, fee stability, or how each behaves during a meaningful market correction. Early-stage funds also face redemption risk and may struggle to manage inflows and outflows efficiently at low assets.

• Derivative exposure (DRAM). DRAM's use of swaps and forward contracts introduces counterparty risk and adds complexity that could widen spreads or cause tracking error if liquidity in those derivative instruments tightens during stress periods.

• Liquidity disparity. KMEM's $26.8M in assets may result in wider bid-ask spreads, higher trading costs for position entry or exit, and vulnerability to large redemptions that could trigger forced selling at unfavorable prices.

Bottom line

DRAM offers the liquidity and scale advantages of a much larger fund with three months more history, while KMEM pursues a simpler direct-stock approach at a fraction of the size. If ease of trading and operational stability matter most, DRAM's scale is a meaningful edge; if you want to monitor a leaner, less-leveraged vehicle, KMEM's structure may appeal. Neither has yet demonstrated how it performs over a full market cycle, so treating either as a long-term core holding carries execution risk.